Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells (neoplasia) or lesions on your outer cervix lining (intraepithelial). CIN can be ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

A retrospective review of comprehensive quality assurance databases of screening tests and cervical biopsy results from the Regional Laboratory of the Kaiser Permanente Northern California (KPNC ...

CIN: Cervical intraepithelial neoplasia; HPV: Human papillomavirus. Genome organization of the papillomavirus. HPV16 from the α9 group of papillomaviruses. HPV: Human papillomavirus; LCR ...

Human papillomavirus (HPV) vaccines are in wide use around the world owing to the widespread implementation of immunization programs for young girls before they become sexually active. The phase ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...

Cervical dysplasia can range from mild to severe, depending on the appearance of the abnormal cells. Another term for cervical dysplasia is cervical intraepithelial neoplasia, or CIN. The exact cause ...

In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical ...

In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical ...

Refika Yigit, MD, principal investigator and oncological gynecologist at University Medical Centre Groningen, Netherlands In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...